INTEGRA LIFESCIENCES HOLDINGS CORP Increase (Decrease) in Other Operating Liabilities
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Increase (Decrease) in Other Operating Liabilities of -$3.15 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2012-02-27
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in other operating liabilities for the quarter ending 2011-12-31 was -$1.88M, a 656.68% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in other operating liabilities for the quarter ending 2011-09-30 was -$1.00M.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in other operating liabilities for the quarter ending 2011-06-30 was -$79.00K, a 103.46% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in other operating liabilities for the quarter ending 2011-03-31 was -$198.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in other operating liabilities for fiscal 2011 was -$3.15M.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in other operating liabilities for fiscal 2010 was -$7.53M.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in other operating liabilities for fiscal 2009 was -$1.14M, a 138.49% decline from fiscal 2008.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in other operating liabilities for fiscal 2008 was $2.95M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$2.88M derived: sum of 2 quarters · filed 2012-02-27 | -$2.96M derived: sum of 3 quarters · filed 2012-02-27 | -$3.15M 10-K · filed 2012-02-27 |
| 2011-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$1.08M derived: sum of 2 quarters · filed 2011-10-31 | -$1.28M 10-Q · filed 2011-10-31 | -$941.00K derived: sum of 4 quarters · filed 2012-02-27 |
| 2011-06-30 | -$79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | -$277.00K 10-Q · filed 2011-08-01 | $60.00K derived: sum of 3 quarters · filed 2012-02-27 | -$7.25M derived: sum of 4 quarters · filed 2012-02-27 |
| 2011-03-31 | -$198.00K 10-Q · filed 2011-04-28 | $139.00K derived: sum of 2 quarters · filed 2012-02-27 | -$7.17M derived: sum of 3 quarters · filed 2012-02-27 | -$4.89M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$6.97M derived: sum of 2 quarters · filed 2012-02-27 | -$4.70M derived: sum of 3 quarters · filed 2012-02-27 | -$7.53M 10-K · filed 2012-02-27 |
| 2010-09-30 | -$7.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$5.03M derived: sum of 2 quarters · filed 2011-10-31 | -$7.87M 10-Q · filed 2011-10-31 | -$9.31M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | -$556.00K 10-Q · filed 2011-08-01 | -$2.00M derived: sum of 3 quarters · filed 2012-02-27 | -$1.81M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | -$2.84M 10-Q · filed 2011-04-28 | -$4.28M derived: sum of 2 quarters · filed 2012-02-27 | -$4.09M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$1.26M derived: sum of 2 quarters · filed 2012-02-27 | -$1.14M 10-K · filed 2012-02-27 | |
| 2009-09-30 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $306.00K 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | $122.00K 10-Q · filed 2010-07-29 | |||
| 2008-12-31 | $2.95M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |